Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001742734-25-000007
Filing Date
2025-10-21
Accepted
2025-10-21 21:17:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3077
  Complete submission text file 0001742734-25-000007.txt   4520
Mailing Address 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017
Business Address 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017 646-860-7985
MeiraGTx Holdings plc (Subject) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38520 | Film No.: 251408420
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MEIRAGTX HOLDINGS PLC 655 THIRD AVENUE -- SUITE 1115 NEW YORK NY 10017
Business Address
Giroux Richard (Reporting) CIK: 0001742734 (see all company filings)

Type: 144